Cumberland pharmaceuticals reports 9% revenue growth in 2020

Nashville, tenn., march 9, 2021 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results.

CPIX Ratings Summary

CPIX Quant Ranking